Towa Pharmaceutical Co., Ltd. Announces Earnings Results for the Second Quarter of Fiscal Year 2015; Provides Earnings Guidance for the Full Year Ending March 2015
November 10, 2014
Share
Towa Pharmaceutical Co., Ltd. announced earnings results for the second quarter of fiscal year 2015. For the period, the company reported net sales of JPY 33,468 million compared to JPY 28,559 million a year ago. Operating income was JPY 4,183 million compared to JPY 3,119 million a year ago. Ordinary income was JPY 5,550 million compared to JPY 3,140 million a year ago. Net income was JPY 4,068 million compared to JPY 2,019 million a year ago.
The company provided earnings guidance for the full year ending March 2015. For the period, the company expected net sales of JPY 72,000 million, operating income of JPY 7,800 million, ordinary income of JPY 7,800 million and net income of JPY 5,300 million.
Towa Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The main products are generic drugs, which are launched after the efficacy and safety of new drugs have been confirmed for a certain period of time. It is a drug with the same effect, usage and dosage. The Company is involved in the sale and outsourced manufacture of products and generic drugs. The Company is involved in the research and outsourced manufacture of active pharmaceutical ingredient and soft capsules. The Company is also involved in the planning, development, contract manufacturing of health foods, general foods, miscellaneous goods and others.
Towa Pharmaceutical Co., Ltd. Announces Earnings Results for the Second Quarter of Fiscal Year 2015; Provides Earnings Guidance for the Full Year Ending March 2015
TOWA PHARMACEUTICAL CO., LTD. 
